Table 3.
Annotation results from GO analysis
| P value | Ratio | ||
|---|---|---|---|
| Pathways | |||
| MAPK signaling pathway | 1.21E−60 | 160 | 287 |
| Wnt signaling pathway | 4.87E−49 | 104 | 159 |
| Insulin signaling pathway | 1.93E−20 | 90 | 230 |
| Notch signaling pathway | 1.09E−18 | 36 | 53 |
| p53 signaling pathway | 3.02E−18 | 46 | 83 |
| GnRH signaling pathway | 3.66E−14 | 60 | 153 |
| Hedgehog signaling pathway | 1.03E−13 | 35 | 65 |
| Networks | |||
| Regulation of actin cytoskeleton | 1.91E−30 | 125 | 303 |
| Focal adhesion | 1.34E−26 | 124 | 324 |
| Cell cycle | 8.90E−23 | 87 | 204 |
| Oocyte meiosis | 1.55E−19 | 70 | 159 |
| ECM-receptor interaction | 3.62E−19 | 57 | 115 |
| Gap junction | 3.09E−16 | 61 | 144 |
| Pancreatic secretion | 2.98E−12 | 61 | 171 |
| Progesterone-mediated oocyte maturation | 1.66E−10 | 52 | 147 |
| Diseases | |||
| Pancreatic cancer | 8.85E−14 | 42 | 88 |
| Type I diabetes mellitus | 1.28E−11 | 30 | 57 |
| Endometrial cancer | 1.56E−09 | 31 | 70 |
| Type II diabetes mellitus | 4.05E−08 | 24 | 52 |
| Maturity onset diabetes of the young | 8.60E−08 | 17 | 30 |
| Metabolisms | |||
| Glycosaminoglycan biosynthesis-heparan sulfate | 6.85E−17 | 23 | 26 |
| N-Glycan biosynthesis | 5.31E−16 | 32 | 49 |
| Starch and sucrose metabolism | 4.34E−13 | 33 | 61 |
| Amino sugar and nucleotide sugar metabolism | 9.32E−09 | 24 | 49 |
| Fructose and mannose metabolism | 2.38E−08 | 22 | 44 |
| Glycine, serine and threonine metabolism | 4.03E−08 | 22 | 45 |
| Galactose metabolism | 6.36E−07 | 16 | 30 |
| Steroid biosynthesis | 9.98E−05 | 10 | 19 |